Detailed Antibiotic Information
Class: Aminopenicillin
Dosing: 500mg–1g PO q8h
Coverage: Gram +
Notes: Better oral absorption than ampicillin
Class: 1st Gen Cephalosporin
Dosing: 500mg PO q6h
Coverage: Gram +
Notes: Excellent for skin/soft tissue infections
Class: Lincosamide
Dosing: 300–450mg PO q6h
Coverage: Gram + Anaerobes MRSA
Notes: Good anaerobic and MRSA coverage
Class: β-lactam/β-lactamase inhibitor
Dosing: 875/125mg PO q12h
Coverage: Gram + Gram - Anaerobes
Notes: Covers β-lactamase producing organisms
Class: 3rd Gen Cephalosporin
Dosing: 1–2g IV daily
Coverage: Gram +Gram -
Notes: Long half-life, good CNS penetration
Class: Macrolide
Dosing: 500mg day 1, then 250mg daily ×4
Coverage: Gram +Atypicals
Notes: Excellent for atypical pneumonia
Class: Glycopeptide
Dosing: 15–20mg/kg IV q8–12h
Coverage: Gram +MRSA
Notes: Gold standard for MRSA
Class: Oxazolidinone
Dosing: 600mg IV/PO q12h
Coverage: Gram +MRSAVRE
Notes: Covers MRSA and VRE
Class: Nitroimidazole
Dosing: 500mg IV/PO q8h
Coverage: Anaerobes
Notes: Excellent anaerobic coverage
Class: 2nd Gen Cephalosporin
Dosing: 750mg–1.5g IV q8h
Coverage: Gram + Gram -
Notes: Good for respiratory tract infections
Class: Fluoroquinolone
Dosing: 400mg IV q12h or 500mg PO q12h
Coverage: Gram - Pseudomonas Atypicals
Notes: Good Pseudomonas coverage
Class: Monobactam
Dosing: 1–2g IV q6–8h
Coverage: Gram - Pseudomonas
Notes: β-lactam safe in penicillin allergy, Gram-negative only
Class: Aminoglycoside
Dosing: 15mg/kg IV daily
Coverage: Gram - Pseudomonas
Notes: Resistant to most aminoglycoside-modifying enzymes
Class: Antipseudomonal Penicillin
Dosing: 4.5g IV q6h
Coverage: Gram + Gram - Pseudomonas Anaerobes
Notes: Broad coverage including Pseudomonas
Class: 4th Gen Cephalosporin
Dosing: 2g IV q8–12h
Coverage: Gram + Gram - Pseudomonas
Notes: Antipseudomonal cephalosporin
Class: Carbapenem
Dosing: 1g IV q8h
Coverage: Gram + Gram - Pseudomonas Anaerobes
Notes: Reserve for serious infections
Class: Respiratory Fluoroquinolone
Dosing: 750mg IV/PO daily
Coverage: Gram + Gram - Atypicals
Notes: Good respiratory and atypical coverage
Class: Lipopeptide
Dosing: 6–10mg/kg IV daily
Coverage: Gram + MRSA VRE
Notes: Not for pneumonia (surfactant inactivation)
Class: Carbapenem
Dosing: 500mg IV q6h
Coverage: Gram + Gram - Pseudomonas Anaerobes
Notes: Very broad spectrum, seizure risk
Class: Glycylcycline
Dosing: 100mg IV loading, then 50mg q12h
Coverage: Gram + Gram - Anaerobes Atypicals MRSA
Notes: Reserved for MDR infections, not for Pseudomonas
Class: Polymyxin
Dosing: 5mg/kg loading, then 2.5mg/kg q12h
Coverage: Gram - Pseudomonas
Notes: Last resort for MDR Gram-negatives, nephrotoxic
Class: Polymyxin
Dosing: 1.5–2.5mg/kg/day divided q12h
Coverage: Gram - Pseudomonas
Notes: Alternative to colistin, less nephrotoxic
Class: Anti-pseudomonal Cephalosporin
Dosing: 1.5g IV q8h
Coverage: Gram - Pseudomonas
Notes: Excellent anti-Pseudomonas activity
Class: Cephalosporin/β-lactamase inhibitor
Dosing: 2.5g IV q8h
Coverage: Gram - Pseudomonas
Notes: Active against KPC-producing organisms
Class: Folate antagonist
Dosing: 8–12mg/kg/day (TMP) q6–12h
Coverage: Gram + Gram - MRSA
Notes: Good for MRSA, Stenotrophomonas, PCP
Class: Tetracycline
Dosing: 100mg PO/IV q12h
Coverage: Gram + Atypicals
Notes: Good for atypicals, some community MRSA
Class: 5th Gen Cephalosporin
Dosing: 600mg IV q12h
Coverage: Gram + Gram - MRSA
Notes: MRSA-active cephalosporin
Class: Oxazolidinone
Dosing: 200mg IV/PO daily
Coverage: Gram + MRSA VRE
Notes: Alternative to linezolid, less toxicity
0 Comments